BioSpace News Archive

Drug Development

Ascletis Announces ASC40, a First-in-Class, Once-Daily Oral FASN Inhibitor, Achieved Endpoints in Phase II Clinical Trial for Acne

Ascletis Pharma Inc. announces that ASC40, a first-in-class, once-daily oral fatty acid synthase inhibitor, achieved primary and key secondary endpoints in Phase II clinical trial for acne vulgaris.

May 2, 2023
·
7 min read
Business

Syneos Health Appoints Michael Bonello as Chief Financial Officer

Syneos Health®, the only fully integrated biopharmaceutical solutions organization, announced the appointment of Michael Bonello as Chief Financial Officer, effective July 1, 2023.

May 2, 2023
·
4 min read
Hyloris announces potential registration date for Maxigesic® IV in the US

Hyloris Pharmaceuticals SA announces the US Food & Drug Administration has set 17 October 2023 as the date by which it expects to respond to the application regarding Maxigesic® IV.

May 2, 2023
·
4 min read
Business

ObsEva Appoints Fabien de Ladonchamps as Chief Executive Officer

ObsEva SA, a biopharmaceutical company developing novel therapies for women’s health, announced that Fabien de Ladonchamps has been appointed Chief Executive Officer effective May 1, 2023.

May 2, 2023
·
3 min read
Policy

Memo Therapeutics AG Receives FDA Fast Track Designation for AntiBKV as Treatment of BKV Infection in Renal Transplant Patients

Memo Therapeutics AG announced that the U.S. Food and Drug Administration has granted Fast Track designation to AntiBKV, MTx’s lead antibody therapeutic that targets BK polyomavirus infection commonly seen in renal transplant patients.

May 2, 2023
·
3 min read
Drug Development

OKYO Pharma Announces First-Patient First-Visit for Phase 2 Trial Evaluating Efficacy and Safety of OK-101 in Patients with Dry Eye Disease

OKYO Pharma Limited is pleased to announce that the first patient has been screened for its phase 2, multi-center, randomized, double–blinded, placebo-controlled trial, evaluating the efficacy and safety of OK-101 ophthalmic solution in subjects with dry eye disease.

May 2, 2023
·
5 min read
Business

Amphista Therapeutics Expands Senior Team and Announces Appointment of Louise Modis as Chief Scientific Officer and Ian Churcher as Chief Technology Officer

Amphista Therapeutics announced that Louise Modis, PhD, has joined the company as Chief Scientific Officer and Ian Churcher, DPhil, will transition to the role of Chief Technology Officer.

May 2, 2023
·
2 min read
Pharm Country

Teleflex Launches New Arrow® VPS Rhythm® DLX Device and NaviCurve™ Stylet in the United States

Teleflex Incorporated today announced the launch of two new devices designed to enhance PICC insertion procedures and reduce the chance of complications.

May 2, 2023
·
5 min read
Medigene expands end-to-end technology platform through worldwide, exclusive license of a CD40L-CD28 Costimulatory Switch Receptor further enhancing potential to treat solid tumors

Medigene AG reports it has partnered with Helmholtz Munich to acquire the exclusive, worldwide rights to the CD40L-CD28 costimulatory switch receptor adding to the portfolio of technologies within Medigene’s end-to-end platform.

May 2, 2023
·
6 min read
Philips extends company’s mobile C-arm portfolio with Zenition 10

Royal Philips, a global leader in health technology, announced the launch of Philips Image Guided Therapy Mobile C-arm System 1000 – Zenition 10, a new addition to the company’s Zenition mobile C-arm series.

May 2, 2023
·
4 min read